Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 46 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A
18(54.5%)
Phase 1
6(18.2%)
Phase 2
4(12.1%)
Phase 4
3(9.1%)
Early Phase 1
2(6.1%)
33Total
N/A(18)
Phase 1(6)
Phase 2(4)
Phase 4(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (46)

Showing 20 of 46 trials
NCT07854002Not Yet Recruiting

Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study

Role: collaborator

NCT05313529Not ApplicableCompleted

LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes

Role: collaborator

NCT04730921Not ApplicableCompleted

Impact of Left Bundle Branch Area Pacing vs. Right Ventricular Pacing in Atrioventricular Block (LEAP-Block)

Role: collaborator

NCT07153744Phase 4Not Yet Recruiting

Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction

Role: collaborator

NCT06848400Not ApplicableRecruiting

Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios

Role: collaborator

NCT05289908Phase 1Completed

Intrathecal Pemetrexed for Leptomeningeal Metastasis

Role: collaborator

NCT06924190Not ApplicableCompleted

Pharmacokinetics and Bioequivalence Study of Budesonide Inhalation Aerosol in Humans

Role: collaborator

NCT04992026Phase 2Completed

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

Role: collaborator

NCT06430502Not ApplicableRecruiting

Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours

Role: lead

NCT06430515Not ApplicableRecruiting

The Clinical Efficacy and Safety of Intratumoral Injection of Chemotherapy for Advanced Solid Tumors

Role: lead

NCT05268172Phase 1Recruiting

IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites

Role: collaborator

NCT06404528Not ApplicableRecruiting

Low-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid Tumours

Role: lead

NCT05861869Unknown

Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)

Role: collaborator

NCT06240767Phase 1Unknown

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Role: lead

NCT06216340Phase 4Not Yet Recruiting

Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes

Role: collaborator

NCT06212882Unknown

Optimization of DE-CTPA Images and Diagnostic Pathway: Using Low Concentration Iodine Contrast Material

Role: lead

NCT06208982Unknown

A Computer-aided (CADx)System in Real-time Characterization of Colorectal Ulcerative Diseases

Role: collaborator

NCT06207825Not Yet Recruiting

Accuracy of Computer-aided (CADx) System in Real-time Characterization of Colorectal Ulcerative Diseases

Role: collaborator

NCT05747339Not ApplicableUnknown

A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors

Role: lead

NCT05557656Unknown

A Real World Study of Regogfinib in HCC

Role: collaborator